Related Experiment Video
Updated: Jul 18, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency
H B Gaspar1, S Howe, A J Thrasher
1Molecular Immunology Unit, Institute of Child Health, London, UK.
Abstract:
Severe combined immunodeficiencies have long been targeted as a group of disorders amenable to gene therapy because of their defined molecular biology and pathophysiology, and the prediction that corrected cells would have profound growth and survival advantage. Recently, several clinical studies have shown that conventional gene transfer technology can produce major beneficial therapeutic effects in these patients, but, as for all cellular and pharmacological treatment approaches, with a finite potential for toxicity.
Related Concept Videos
What is Genetic Engineering?
Gene Therapy
Gene Therapy
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Microorganisms in Medicine and Therapeutics

